Technically, Usha Martin stock is trading well above its 20, 50, 100, and 200-day SMAs, reflecting robust underlying strength and a favourable trend structure, says Axis Securities in a note.
Despite trading in overbought territory Delhivery, Metropolis Health look poised for up to 19% further gains, while Usha Martin stock could dip 9%; suggest technical charts.